Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;7(7):2745-88.
doi: 10.3390/ijerph7072745. Epub 2010 Jun 28.

Chelation in metal intoxication

Swaran J S Flora  1 , Vidhu Pachauri
Affiliations
Review

Chelation in metal intoxication

Swaran J S Flora et al. Int J Environ Res Public Health. 2010 Jul.

Abstract

Chelation therapy is the preferred medical treatment for reducing the toxic effects of metals. Chelating agents are capable of binding to toxic metal ions to form complex structures which are easily excreted from the body removing them from intracellular or extracellular spaces. 2,3-Dimercaprol has long been the mainstay of chelation therapy for lead or arsenic poisoning, however its serious side effects have led researchers to develop less toxic analogues. Hydrophilic chelators like meso-2,3-dimercaptosuccinic acid effectively promote renal metal excretion, but their ability to access intracellular metals is weak. Newer strategies to address these drawbacks like combination therapy (use of structurally different chelating agents) or co-administration of antioxidants have been reported recently. In this review we provide an update of the existing chelating agents and the various strategies available for the treatment of heavy metals and metalloid intoxications.

Keywords: antioxidant; chelating agents; combination therapy; heavy metals; monoesters; oxidative stress; succimer.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Formation of metal ligand complexes using mono, bi and polydentate ligands.
Figure 2.
Figure 2.
Characteristics of an ideal chelating agent for better chelation of heavy metals.
Figure 3.
Figure 3.
Structures of two different complexes of metals with chelating agents. (A) Stable complex prevent interaction of metal with bio-molecules, (B) Basket complex enhance interaction of metal with bio-molecules. Symbols used: B- Bio-molecules; C-Chelating agent; M-Metal.
Figure 4.
Figure 4.
Structures of various chelating agents used to treat cases of heavy metal poisoning.
Figure 5.
Figure 5.
Chemical reaction of lewisite with British Anti Lewisite (BAL) to give a stable 5-membered ring complex.
Figure 6.
Figure 6.
Limitations of DMSA in the treatment of mercury toxicity.
Figure 7.
Figure 7.
Newly synthesized monoesters of DMSA.
Figure 8.
Figure 8.
Benefits and drawbacks of chelation therapy.
Figure 9.
Figure 9.
Beneficial effects of combination therapy.
Figure 10.
Figure 10.
Acute and chronic exposure symptoms of metal toxicity and possible preventive and therapeutic measures against them.
Figure 11.
Figure 11.
showing possible mechanism involved for the better therapeutic efficacy of combined chelation therapy in lead/arsenic poisoning using two different chelating agents.
See this image and copyright information in PMC

References

    1. Morgan T, Gilbert T, Drew, Harry DK. CLXII—Researches on residual affinity and co-ordination. Part II Acetyl acetones of selenium and tellurium. J. Chem. Soc. 1920;117:1456–1465.
    1. Andersen O. Principles and recent developments in chelation treatment of metal intoxication. Chem. Rev. 1999;99:2683–2710. - PubMed
    1. Jones MM. Design of new chelating agents for removal of intracellular toxic metals. In: Kauffman GB, editor. Coordination Chemistry: A Century of Progress. The American Chemical Society; Washington, DC, USA: 1994. pp. 427–438.
    1. Baum CR. Treatment of mercury intoxication. Curr. Opin. Pediatr. 1999;11:265–268. - PubMed
    1. Guldager B, Jorgensen PJ, Grandjean P. Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA. Clin. Chem. 1996;42:1938–1942. - PubMed

Publication types

LinkOut - more resources